´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2023-06-30
±³À°ÀÏÀÚ : 2023-06-30
±³À°Àå¼Ò : ¿þ½ºÆ¾ Á¶¼± ºÎ»ê
±³À°ÁÖÁ¦ : KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁ¾¾ç³»°úÇÐȸ ºÎ»ê ¿ï»ê °æ³²Áöȸ
´ã´çÀÚ : Â÷¹ÎÁÖ
¿¬¶ôó : 070-4044-5337
À̸ÞÀÏ : minju.cha@ksmo.or.kr
±³À°Á¾·ù : ³»°ú, ¹æ»ç¼±Á¾¾çÇаú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 55ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 30ÀÏ ±×·£µåº¼·ë 14:30~14:55 Chemotherpay S/E management ÃÖÇõÁø(°æºÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 30ÀÏ ±×·£µåº¼·ë 14:55~15:20 CIPN(Chemotherapy-induced peripheral neuropathy) ÀÌ»óÇå(ºÎ»ê´ë)
±³À°½Ã°£ 06¿ù 30ÀÏ ±×·£µåº¼·ë 15:20~15:45 Cancer associated venous thromboembolic disease ȲÀ±Èñ(´ë±¸°¡Å縯ÀÇ´ë)
Åä·Ð 06¿ù 30ÀÏ ±×·£µåº¼·ë 15:45~16:00 Q&A ()
ÈÞ½Ä 06¿ù 30ÀÏ ±×·£µåº¼·ë 16:00~16:20 Coffee Break ()
±³À°½Ã°£ 06¿ù 30ÀÏ ±×·£µåº¼·ë 16:20~16:50 Sotorasib Àü¿µ°æ(¾ç»êºÎ»ê´ë)
±³À°½Ã°£ 06¿ù 30ÀÏ ±×·£µåº¼·ë 16:50~17:15 trastuzumab deruxtecan : À¯¹æ¾Ï ÀÌÀÎÈñ(°æºÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 30ÀÏ ±×·£µåº¼·ë 17:15~17:40 trastuzumab deruxtecan : À§¾Ï Á¤Çö¿±(°í½Å´ë)
±³À°½Ã°£ 06¿ù 30ÀÏ ±×·£µåº¼·ë 17:40~18:05 Chemotherapy-induced Anemia ±èÇý·Ã(µ¿¾Æ´ë)
±³À°½Ã°£ 06¿ù 30ÀÏ ±×·£µåº¼·ë 18:05~18:30 Oral mucositis ÀÌ»óȯ(ÆÄƼ¸¶)
Åä·Ð 06¿ù 30ÀÏ ±×·£µåº¼·ë 18:30~18:45 Q&A ()